Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells

Xuehua Liu, Liming Yang, Huiyan Wang, Guofeng Xu, Shasha Zhu, Mengmeng Li, Xiaoshan Hu, Jingai Zhu, Chun Zhu, Jing Xu, Shuping Han, Zhangbin Yu

Research output: Contribution to journalArticle

Abstract

MicroRNA-19b (miR-19b) is part of the miR-17-92 cluster which is associated with cardiac development. It has previously been reported that the overexpression of miR-19b increases proliferation, inhibits apoptosis and promotes differentiation of embryonic carcinoma cells (P19 cells). The aim of the current study was to investigate the effects of miR-19b knockdown on the proliferation, apoptosis, differentiation and regulation of the Wnt/β-catenin signaling pathway in P19 cells. P19 cells were transfected with an miR-19b knockdown plasmid or an empty vector. MiR-19b knockdown or vector control stable cell lines were selected using puromycin. Cell Counting kit-8 and flow cytometry were used to analyze the levels of cellular proliferation, cell cycle progression and the levels of apoptosis, respectively. Caspase-3 activity and mitochondrial function assays were also used to analyze apoptosis. An inverted microscope was used to observe the morphological changes of P19 cells during differentiation. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were used to detect P19 cell differentiation markers and Wnt/β-catenin signaling pathway-related genes and their corresponding proteins. The results demonstrated that miR-19b knockdown inhibited the proliferation and apoptosis of P19 cells. However, the levels of expression of Wnt and β-catenin increased. MiR-19b knockdown activated the Wnt/β-catenin signaling pathway, which may regulate cardiomyocyte differentiation. The results of this study indicate that miR-19b is a novel therapeutic target for cardiovascular diseases and provide insight into the mechanisms underlying congenital heart diseases.

Original languageEnglish (US)
Pages (from-to)2504-2512
Number of pages9
JournalMolecular Medicine Reports
Volume11
Issue number4
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

MicroRNAs
Catenins
Cells
Carcinoma
Wnt Signaling Pathway
Apoptosis
Cell Differentiation
Puromycin
Flow cytometry
Polymerase chain reaction
Differentiation Antigens
Cell proliferation
Transcription
Cardiac Myocytes
Caspase 3
Reverse Transcription
Heart Diseases
Assays
Cell Cycle
Flow Cytometry

Keywords

  • Apoptosis
  • Congenital heart disease
  • Mir-19b knockdown
  • P19 cells

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Oncology
  • Cancer Research

Cite this

Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells. / Liu, Xuehua; Yang, Liming; Wang, Huiyan; Xu, Guofeng; Zhu, Shasha; Li, Mengmeng; Hu, Xiaoshan; Zhu, Jingai; Zhu, Chun; Xu, Jing; Han, Shuping; Yu, Zhangbin.

In: Molecular Medicine Reports, Vol. 11, No. 4, 01.01.2015, p. 2504-2512.

Research output: Contribution to journalArticle

Liu, X, Yang, L, Wang, H, Xu, G, Zhu, S, Li, M, Hu, X, Zhu, J, Zhu, C, Xu, J, Han, S & Yu, Z 2015, 'Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells', Molecular Medicine Reports, vol. 11, no. 4, pp. 2504-2512. https://doi.org/10.3892/mmr.2014.3037
Liu, Xuehua ; Yang, Liming ; Wang, Huiyan ; Xu, Guofeng ; Zhu, Shasha ; Li, Mengmeng ; Hu, Xiaoshan ; Zhu, Jingai ; Zhu, Chun ; Xu, Jing ; Han, Shuping ; Yu, Zhangbin. / Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells. In: Molecular Medicine Reports. 2015 ; Vol. 11, No. 4. pp. 2504-2512.
@article{72850d74e02a43b5998ecbdb1331cc2c,
title = "Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells",
abstract = "MicroRNA-19b (miR-19b) is part of the miR-17-92 cluster which is associated with cardiac development. It has previously been reported that the overexpression of miR-19b increases proliferation, inhibits apoptosis and promotes differentiation of embryonic carcinoma cells (P19 cells). The aim of the current study was to investigate the effects of miR-19b knockdown on the proliferation, apoptosis, differentiation and regulation of the Wnt/β-catenin signaling pathway in P19 cells. P19 cells were transfected with an miR-19b knockdown plasmid or an empty vector. MiR-19b knockdown or vector control stable cell lines were selected using puromycin. Cell Counting kit-8 and flow cytometry were used to analyze the levels of cellular proliferation, cell cycle progression and the levels of apoptosis, respectively. Caspase-3 activity and mitochondrial function assays were also used to analyze apoptosis. An inverted microscope was used to observe the morphological changes of P19 cells during differentiation. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were used to detect P19 cell differentiation markers and Wnt/β-catenin signaling pathway-related genes and their corresponding proteins. The results demonstrated that miR-19b knockdown inhibited the proliferation and apoptosis of P19 cells. However, the levels of expression of Wnt and β-catenin increased. MiR-19b knockdown activated the Wnt/β-catenin signaling pathway, which may regulate cardiomyocyte differentiation. The results of this study indicate that miR-19b is a novel therapeutic target for cardiovascular diseases and provide insight into the mechanisms underlying congenital heart diseases.",
keywords = "Apoptosis, Congenital heart disease, Mir-19b knockdown, P19 cells",
author = "Xuehua Liu and Liming Yang and Huiyan Wang and Guofeng Xu and Shasha Zhu and Mengmeng Li and Xiaoshan Hu and Jingai Zhu and Chun Zhu and Jing Xu and Shuping Han and Zhangbin Yu",
year = "2015",
month = "1",
day = "1",
doi = "10.3892/mmr.2014.3037",
language = "English (US)",
volume = "11",
pages = "2504--2512",
journal = "Molecular Medicine Reports",
issn = "1791-2997",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Effects of miR-19b knockdown on the cardiac differentiation of P19 mouse embryonic carcinoma cells

AU - Liu, Xuehua

AU - Yang, Liming

AU - Wang, Huiyan

AU - Xu, Guofeng

AU - Zhu, Shasha

AU - Li, Mengmeng

AU - Hu, Xiaoshan

AU - Zhu, Jingai

AU - Zhu, Chun

AU - Xu, Jing

AU - Han, Shuping

AU - Yu, Zhangbin

PY - 2015/1/1

Y1 - 2015/1/1

N2 - MicroRNA-19b (miR-19b) is part of the miR-17-92 cluster which is associated with cardiac development. It has previously been reported that the overexpression of miR-19b increases proliferation, inhibits apoptosis and promotes differentiation of embryonic carcinoma cells (P19 cells). The aim of the current study was to investigate the effects of miR-19b knockdown on the proliferation, apoptosis, differentiation and regulation of the Wnt/β-catenin signaling pathway in P19 cells. P19 cells were transfected with an miR-19b knockdown plasmid or an empty vector. MiR-19b knockdown or vector control stable cell lines were selected using puromycin. Cell Counting kit-8 and flow cytometry were used to analyze the levels of cellular proliferation, cell cycle progression and the levels of apoptosis, respectively. Caspase-3 activity and mitochondrial function assays were also used to analyze apoptosis. An inverted microscope was used to observe the morphological changes of P19 cells during differentiation. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were used to detect P19 cell differentiation markers and Wnt/β-catenin signaling pathway-related genes and their corresponding proteins. The results demonstrated that miR-19b knockdown inhibited the proliferation and apoptosis of P19 cells. However, the levels of expression of Wnt and β-catenin increased. MiR-19b knockdown activated the Wnt/β-catenin signaling pathway, which may regulate cardiomyocyte differentiation. The results of this study indicate that miR-19b is a novel therapeutic target for cardiovascular diseases and provide insight into the mechanisms underlying congenital heart diseases.

AB - MicroRNA-19b (miR-19b) is part of the miR-17-92 cluster which is associated with cardiac development. It has previously been reported that the overexpression of miR-19b increases proliferation, inhibits apoptosis and promotes differentiation of embryonic carcinoma cells (P19 cells). The aim of the current study was to investigate the effects of miR-19b knockdown on the proliferation, apoptosis, differentiation and regulation of the Wnt/β-catenin signaling pathway in P19 cells. P19 cells were transfected with an miR-19b knockdown plasmid or an empty vector. MiR-19b knockdown or vector control stable cell lines were selected using puromycin. Cell Counting kit-8 and flow cytometry were used to analyze the levels of cellular proliferation, cell cycle progression and the levels of apoptosis, respectively. Caspase-3 activity and mitochondrial function assays were also used to analyze apoptosis. An inverted microscope was used to observe the morphological changes of P19 cells during differentiation. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were used to detect P19 cell differentiation markers and Wnt/β-catenin signaling pathway-related genes and their corresponding proteins. The results demonstrated that miR-19b knockdown inhibited the proliferation and apoptosis of P19 cells. However, the levels of expression of Wnt and β-catenin increased. MiR-19b knockdown activated the Wnt/β-catenin signaling pathway, which may regulate cardiomyocyte differentiation. The results of this study indicate that miR-19b is a novel therapeutic target for cardiovascular diseases and provide insight into the mechanisms underlying congenital heart diseases.

KW - Apoptosis

KW - Congenital heart disease

KW - Mir-19b knockdown

KW - P19 cells

UR - http://www.scopus.com/inward/record.url?scp=84921327960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921327960&partnerID=8YFLogxK

U2 - 10.3892/mmr.2014.3037

DO - 10.3892/mmr.2014.3037

M3 - Article

C2 - 25483911

AN - SCOPUS:84921327960

VL - 11

SP - 2504

EP - 2512

JO - Molecular Medicine Reports

JF - Molecular Medicine Reports

SN - 1791-2997

IS - 4

ER -